Press Releases Letter: Acting FDA Commissioner Woodcock, Other Top Officials Must Resign Following Indefensible Aducanumab Approval June 16, 2021
Press Releases Federal Agencies Must Investigate Serious Regulatory, Ethical Lapses in Reckless Epilepsy Clinical Trial Funded by NIH June 8, 2021
Press Releases Statement: FDA’s Decision to Approve Aducanumab for Alzheimer’s Disease Shows Reckless Disregard for Science, Severely Damages Agency’s Credibility June 7, 2021
Press Releases Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit March 23, 2021
Press Releases Statement: NIAID’s Statement on AstraZeneca’s Vaccine is Remarkable and Troubling March 23, 2021
Press Releases Disseminating Preliminary, Incomplete COVID-19 Vaccine Study Results by Press Release Represents Bad Science November 9, 2020
Press Releases FDA Approval of Aducanumab to Treat Alzheimer’s Disease Would Be a Reckless Disregard for Science, Damage Agency’s Credibility November 5, 2020
Press Releases FDA’s COVID-19 Vaccine Emergency Use Authorization Would Rely on Seriously Deficient Vaccination Data October 23, 2020
Press Releases Federal Regulators’ Failure to Act Endangered CLOVERS Trial Patients After Alarming Design Flaws, Ethical Lapses Were Identified October 13, 2020